NCT02455908View on ClinicalTrials.gov

IL-2 for Multi Drug Resistant Nephrotic Syndrome

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Nephrotic Syndrome
Interventions
DRUG

Proleukin®

Trial Locations (1)

16147

Istituto Giannina Gaslini, Genova

All Listed Sponsors
lead

Istituto Giannina Gaslini

OTHER

NCT02455908 - IL-2 for Multi Drug Resistant Nephrotic Syndrome | Biotech Hunter | Biotech Hunter